Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Stage II-III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Study completedNCT00022087
What this trial is testing

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Alliance for Clinical Trials in Oncology 439
Early research (Phase 1)Study completedNCT01606241
What this trial is testing

Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+24 more
Mayo Clinic 24
Not applicableStudy completedNCT00005957
What this trial is testing

Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 1,832
Not applicableLooking for participantsNCT06721065
What this trial is testing

Language Interpretation Solutions for People With Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IIBreast Cancer Stage III
Memorial Sloan Kettering Cancer Center 700
Large-scale testing (Phase 3)Ended earlyNCT01077154
What this trial is testing

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Who this might be right for
Breast Cancer
Amgen 4,509
Testing effectiveness (Phase 2)Active Not RecruitingNCT04486911
What this trial is testing

Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial

Who this might be right for
Breast Cancer
Shengjing Hospital 89
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012100
What this trial is testing

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaBreast Inflammatory CarcinomaStage IB Breast Cancer AJCC v7+9 more
Academic and Community Cancer Research United 280
Testing effectiveness (Phase 2)Study completedNCT00006256
What this trial is testing

Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 44
Large-scale testing (Phase 3)Active Not RecruitingNCT02488967
What this trial is testing

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaEstrogen Receptor NegativeHER2/Neu Negative+7 more
NRG Oncology 782
Testing effectiveness (Phase 2)Study completedNCT00262834
What this trial is testing

Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)UnknownNCT03044730
What this trial is testing

Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+7 more
Northwestern University 30
Testing effectiveness (Phase 2)Study completedNCT01869764
What this trial is testing

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituMale Breast Cancer+6 more
Wake Forest University Health Sciences 57